Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Epigenetic Dysregulation of GATA1 but Not Downstream Notch Effectors is Involved in MDS Dyserythropoiesis.

Olaf Joachim Hopfer, MD, Martina Komor, PhD, Claudia Freitag, Maximilian Mossner, Dieter Hoelzer, MD, PhD, Eckhard Thiel, MD, PhD, Wolf-Karsten Hofmann, MD, PhD

Blood (2008) 112 (11): 1652.

https://doi.org/10.1182/blood.V112.11.1652.1652

Published: 2008

Journal Articles

GATA and BCLxl Downregulation in Erythropoiesis during In Vitro Lineage Specific Differentiation of MDS Hematopoietic Progenitor Cells Is Not Induced by Activated Notch Pathway.

Olaf J. Hopfer, MD, Martina Komor, PhD, Ina S.N. Koehler, Claudia Freitag, Dieter Hoelzer, MD,PhD, Eckhard Thiel, MD,PhD, Wolf-Karsten Hofmann, MD,PhD

Blood (2007) 110 (11): 4118.

https://doi.org/10.1182/blood.V110.11.4118.4118

Published: 2007

Journal Articles

Survivin Isoforms and HSP90 Are Downregulated in Erythropoiesis during Lineage Specific Differentiation of MDS Hematopoietic Progenitor Cells.

Olaf J. Hopfer, MD, Martina Komor, PhD, Ina S. Koehler, Matthias Schulze, PhD, Claudia Freitag, Dieter Hoelzer, MD, PhD, Eckhard Thiel, MD, PhD, Wolf-Karsten Hofmann, MD, PhD

Blood (2006) 108 (11): 2541.

https://doi.org/10.1182/blood.V108.11.2541.2541

Published: 2006

Journal Articles

Expression of DNMT Isoforms Is Differentially Associated with Aberrant Promotor Methylation in MDS Hematopoietic Progenitor Cells during Lineage Specific Differentiation.

Olaf J. Hopfer, MD, Martina Komor, PhD, Ina S. Koehler, Matthias Schulze, PhD, Claudia Freitag, Dieter Hoelzer, MD,PhD, Eckhard Thiel, MD,PhD, Wolf-Karsten Hofmann, MD,PhD

Blood (2006) 108 (11): 2628.

https://doi.org/10.1182/blood.V108.11.2628.2628

Published: 2006

Journal Articles

Identification of MDS-Specific and Methylation Associated Downregulation of Survivine and WT1 in Highly Purified Hematopoietic Progenitor Cells during In Vitro Lineage Specific Differentiation.

Olaf J. Hopfer, MD, Martina Komor, MD, Dieter Hoelzer, MD, PhD, Eckhard Thiel, MD, PhD, Wolf-Karsten Hofmann, MD, PhD

Blood (2005) 106 (11): 3442.

https://doi.org/10.1182/blood.V106.11.3442.3442

Published: 2005

Journal Articles

Identification of Defects in the Transcriptional Program during Differentiation of CD34+Cells Selected from Patients with Both, Low- and High-Risk Myelodysplastic Syndromes.

Martina Komor, Saskia Gueller, MD, Sven de Vos, Oliver G. Ottmann, MD, Dieter Hoelzer, MD, Wolf-Karsten Hofmann, MD

Blood (2004) 104 (11): 201.

https://doi.org/10.1182/blood.V104.11.201.201

Published: 2004

Journal Articles

In Vivo Drug-Response in Patients with Leukemic Non-Hodgkin’s Lymphomas Is Predicted by In Vitro Chemosensitivity Testing and Gene Expression Profiling.

Kai Uwe Chow, MD, Daniel Nowak, Soo-Zin Kim, MD, Bernd Schneider, Martina Komor, Simone Boehrer, MD, Paris S. Mitrou, MD, Dieter Hoelzer, Eckhart Weidmann, Wolf-Karsten Hofmann

Blood (2004) 104 (11): 2273.

https://doi.org/10.1182/blood.V104.11.2273.2273

Published: 2004

Journal Articles

Significant Down-Regulation of BAALC during Lineage Specific Hematopoietic Differentiation.

Claudia D. Baldus, MD, Martina Komor, MS, Dieter Hoelzer, MD, Albert de la Chapelle, MD PhD, Eckhard Thiel, MD, Wolf-Karsten Hofmann, MD

Blood (2004) 104 (11): 4189.

https://doi.org/10.1182/blood.V104.11.4189.4189

Published: 2004

Journal Articles

Identification of Putative New Tumor Suppressor Genes in Highly Purified CD34+ Bone Marrow Cells from Patients with Myelodysplastic Syndromes.

Saskia Gueller, MD, Martina Komor, Julian C. Desmond, MD, Oliver G. Ottmann, MD, Dieter Hoelzer, MD, H. Phillip Koeffler, MD, Wolf-Karsten Hofmann, MD

Blood (2004) 104 (11): 204.

https://doi.org/10.1182/blood.V104.11.204.204

Published: 2004

Journal Articles

Inhibitory effect of imatinib on normal progenitor cells in vitro

Kerol Bartolovic, Stefan Balabanov, Ulrike Hartmann, Martina Komor, Andreas M. Boehmler, Hans-Jörg Bühring, Robert Möhle, Dieter Hoelzer, Lothar Kanz, Wolf-Karsten Hofmann, Tim H. Brümmendorf

Blood (2004) 103 (2): 523–529.

https://doi.org/10.1182/blood-2003-05-1535

Published: 2004

Journal Articles

Presence of the BCR-ABL mutation Glu255Lys prior to STI571 (imatinib) treatment in patients with Ph + acute lymphoblastic leukemia

Wolf-Karsten Hofmann, Martina Komor, Barbara Wassmann, Letetia C. Jones, Harald Gschaidmeier, Dieter Hoelzer, H. Phillip Koeffler, Oliver G. Ottmann

Blood (2003) 102 (2): 659–661.

https://doi.org/10.1182/blood-2002-06-1756

Published: 2003

Journal Articles

Characterization of gene expression of CD34 + cells from normal and myelodysplastic bone marrow

Wolf-K. Hofmann, Sven de Vos, Martina Komor, Dieter Hoelzer, William Wachsman, H. Phillip Koeffler

Blood (2002) 100 (10): 3553–3560.

https://doi.org/10.1182/blood.V100.10.3553

Published: 2002

NARROW

Epigenetic Dysregulation of GATA1 but Not Downstream Notch Effectors is Involved in MDS Dyserythropoiesis.

GATA and BCLxl Downregulation in Erythropoiesis during In Vitro Lineage Specific Differentiation of MDS Hematopoietic Progenitor Cells Is Not Induced by Activated Notch Pathway.

Survivin Isoforms and HSP90 Are Downregulated in Erythropoiesis during Lineage Specific Differentiation of MDS Hematopoietic Progenitor Cells.

Expression of DNMT Isoforms Is Differentially Associated with Aberrant Promotor Methylation in MDS Hematopoietic Progenitor Cells during Lineage Specific Differentiation.

Identification of MDS-Specific and Methylation Associated Downregulation of Survivine and WT1 in Highly Purified Hematopoietic Progenitor Cells during In Vitro Lineage Specific Differentiation.

Identification of Defects in the Transcriptional Program during Differentiation of CD34+Cells Selected from Patients with Both, Low- and High-Risk Myelodysplastic Syndromes.

In Vivo Drug-Response in Patients with Leukemic Non-Hodgkin’s Lymphomas Is Predicted by In Vitro Chemosensitivity Testing and Gene Expression Profiling.

Significant Down-Regulation of BAALC during Lineage Specific Hematopoietic Differentiation.

Identification of Putative New Tumor Suppressor Genes in Highly Purified CD34+ Bone Marrow Cells from Patients with Myelodysplastic Syndromes.

Inhibitory effect of imatinib on normal progenitor cells in vitro

Presence of the BCR-ABL mutation Glu255Lys prior to STI571 (imatinib) treatment in patients with Ph + acute lymphoblastic leukemia

Characterization of gene expression of CD34 + cells from normal and myelodysplastic bone marrow

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only